Related Experiment Video
Updated: May 31, 2026
06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Nanotechnology in ocular delivery: current and future directions
Yasmin Sultana1, D P Maurya, Z Iqbal
1Department of Pharmaceutics, Hamdard University, New Delhi, India. yas2312003@yahoo.com
Drugs of Today (Barcelona, Spain : 1998)
|June 23, 2011
Summary
Nanotechnology offers advanced ocular drug delivery systems for treating posterior eye diseases. Nano-ophthalmology is crucial for developing effective treatments for conditions like macular degeneration and retinopathy.
Area of Science:
- Ophthalmology
- Nanotechnology
- Drug Delivery
Background:
- Ocular drug delivery knowledge is rapidly expanding.
- Nanotechnology advancements have led to novel drug delivery systems like nanoparticles and liposomes.
- Effective treatment for posterior eye segment diseases requires advanced delivery methods.
Purpose of the Study:
- To review the current status and progress of nanotechnology-based ocular drug delivery systems.
- To highlight the importance of nano-ophthalmology for treating posterior eye diseases.
- To outline future directions in the field.
Main Methods:
- Review of current literature on nanotechnology in ocular drug delivery.
- Analysis of various nanotechnology-based systems (nanoparticles, microemulsions, liposomes, etc.).
- Discussion of challenges and successes in delivering drugs to the posterior eye segment.
Main Results:
- Nanotechnology has enabled diverse ocular drug delivery systems.
- Successful outcomes have been demonstrated for treating posterior eye segment diseases.
- Nano-ophthalmology shows significant promise for managing blinding eye conditions.
Conclusions:
- Nanotechnology is revolutionizing ocular drug delivery, particularly for posterior segment diseases.
- Further focus on nano-ophthalmology is essential for advancing treatments for conditions like retinopathy and macular degeneration.
- Continued research is needed to optimize these systems for safe and effective drug delivery to the eye.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...